Trial Profile
The effect of combination therapy with anti-hypertensive drugs on central blood pressure.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Feb 2013
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Azelnidipine (Primary) ; Olmesartan medoxomil (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 11 Feb 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 06 Mar 2012 New trial record